nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Granisetron—CYP1A1—lung cancer	0.00357	0.769	CrCbGaD
Hyoscyamine—Scopolamine—ABCB1—lung cancer	0.00107	0.23	CrCbGaD
Hyoscyamine—Hyperhidrosis—Cisplatin—lung cancer	0.00066	0.000709	CcSEcCtD
Hyoscyamine—Asthenia—Vinorelbine—lung cancer	0.000654	0.000703	CcSEcCtD
Hyoscyamine—Arrhythmia—Docetaxel—lung cancer	0.000653	0.000702	CcSEcCtD
Hyoscyamine—Dyspnoea—Gemcitabine—lung cancer	0.000653	0.000702	CcSEcCtD
Hyoscyamine—Chest pain—Etoposide—lung cancer	0.000652	0.000701	CcSEcCtD
Hyoscyamine—Nausea—Vinblastine—lung cancer	0.000651	0.0007	CcSEcCtD
Hyoscyamine—Somnolence—Gemcitabine—lung cancer	0.000651	0.0007	CcSEcCtD
Hyoscyamine—Convulsion—Paclitaxel—lung cancer	0.000651	0.000699	CcSEcCtD
Hyoscyamine—Fatigue—Irinotecan—lung cancer	0.000648	0.000696	CcSEcCtD
Hyoscyamine—Pruritus—Vinorelbine—lung cancer	0.000645	0.000693	CcSEcCtD
Hyoscyamine—Constipation—Irinotecan—lung cancer	0.000643	0.000691	CcSEcCtD
Hyoscyamine—Pain—Irinotecan—lung cancer	0.000643	0.000691	CcSEcCtD
Hyoscyamine—Mental disorder—Docetaxel—lung cancer	0.000641	0.000689	CcSEcCtD
Hyoscyamine—Chest pain—Paclitaxel—lung cancer	0.000639	0.000687	CcSEcCtD
Hyoscyamine—Hypotension—Cisplatin—lung cancer	0.000638	0.000685	CcSEcCtD
Hyoscyamine—Anxiety—Paclitaxel—lung cancer	0.000637	0.000685	CcSEcCtD
Hyoscyamine—Erythema—Docetaxel—lung cancer	0.000637	0.000684	CcSEcCtD
Hyoscyamine—Nausea—Topotecan—lung cancer	0.000633	0.00068	CcSEcCtD
Hyoscyamine—Fatigue—Gemcitabine—lung cancer	0.000631	0.000678	CcSEcCtD
Hyoscyamine—Confusional state—Etoposide—lung cancer	0.00063	0.000677	CcSEcCtD
Hyoscyamine—Cardiac arrest—Doxorubicin—lung cancer	0.000627	0.000674	CcSEcCtD
Hyoscyamine—Constipation—Gemcitabine—lung cancer	0.000626	0.000673	CcSEcCtD
Hyoscyamine—Pain—Gemcitabine—lung cancer	0.000626	0.000673	CcSEcCtD
Hyoscyamine—Nausea—Erlotinib—lung cancer	0.000626	0.000673	CcSEcCtD
Hyoscyamine—Dry mouth—Paclitaxel—lung cancer	0.000625	0.000672	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Etoposide—lung cancer	0.000625	0.000672	CcSEcCtD
Hyoscyamine—Diarrhoea—Vinorelbine—lung cancer	0.000624	0.00067	CcSEcCtD
Hyoscyamine—Dysgeusia—Docetaxel—lung cancer	0.000623	0.00067	CcSEcCtD
Hyoscyamine—Ataxia—Doxorubicin—lung cancer	0.00062	0.000667	CcSEcCtD
Hyoscyamine—Feeling abnormal—Irinotecan—lung cancer	0.000619	0.000666	CcSEcCtD
Hyoscyamine—Confusional state—Paclitaxel—lung cancer	0.000618	0.000664	CcSEcCtD
Hyoscyamine—Dysuria—Methotrexate—lung cancer	0.000616	0.000662	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Irinotecan—lung cancer	0.000615	0.000661	CcSEcCtD
Hyoscyamine—Dehydration—Doxorubicin—lung cancer	0.000614	0.000659	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Paclitaxel—lung cancer	0.000613	0.000659	CcSEcCtD
Hyoscyamine—Oedema—Paclitaxel—lung cancer	0.000613	0.000659	CcSEcCtD
Hyoscyamine—Tachycardia—Etoposide—lung cancer	0.00061	0.000656	CcSEcCtD
Hyoscyamine—Dyspnoea—Cisplatin—lung cancer	0.000608	0.000654	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Methotrexate—lung cancer	0.000607	0.000652	CcSEcCtD
Hyoscyamine—Dry skin—Doxorubicin—lung cancer	0.000605	0.00065	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Etoposide—lung cancer	0.000604	0.00065	CcSEcCtD
Hyoscyamine—Feeling abnormal—Gemcitabine—lung cancer	0.000603	0.000648	CcSEcCtD
Hyoscyamine—Shock—Paclitaxel—lung cancer	0.000603	0.000648	CcSEcCtD
Hyoscyamine—Dizziness—Vinorelbine—lung cancer	0.000603	0.000648	CcSEcCtD
Hyoscyamine—Hypokalaemia—Doxorubicin—lung cancer	0.0006	0.000645	CcSEcCtD
Hyoscyamine—Tachycardia—Paclitaxel—lung cancer	0.000598	0.000643	CcSEcCtD
Hyoscyamine—Abdominal pain—Irinotecan—lung cancer	0.000594	0.000639	CcSEcCtD
Hyoscyamine—Body temperature increased—Irinotecan—lung cancer	0.000594	0.000639	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Paclitaxel—lung cancer	0.000593	0.000637	CcSEcCtD
Hyoscyamine—Drowsiness—Methotrexate—lung cancer	0.000587	0.000631	CcSEcCtD
Hyoscyamine—Depression—Methotrexate—lung cancer	0.000585	0.000629	CcSEcCtD
Hyoscyamine—Hypotension—Etoposide—lung cancer	0.000584	0.000628	CcSEcCtD
Hyoscyamine—Pain—Cisplatin—lung cancer	0.000584	0.000627	CcSEcCtD
Hyoscyamine—Vomiting—Vinorelbine—lung cancer	0.000579	0.000623	CcSEcCtD
Hyoscyamine—Body temperature increased—Gemcitabine—lung cancer	0.000579	0.000622	CcSEcCtD
Hyoscyamine—Rash—Vinorelbine—lung cancer	0.000575	0.000618	CcSEcCtD
Hyoscyamine—Dermatitis—Vinorelbine—lung cancer	0.000574	0.000617	CcSEcCtD
Hyoscyamine—Abdominal distension—Doxorubicin—lung cancer	0.000574	0.000617	CcSEcCtD
Hyoscyamine—Hypotension—Paclitaxel—lung cancer	0.000573	0.000616	CcSEcCtD
Hyoscyamine—Headache—Vinorelbine—lung cancer	0.000571	0.000614	CcSEcCtD
Hyoscyamine—Syncope—Docetaxel—lung cancer	0.000571	0.000614	CcSEcCtD
Hyoscyamine—Conjunctivitis—Methotrexate—lung cancer	0.000571	0.000613	CcSEcCtD
Hyoscyamine—Dysphagia—Doxorubicin—lung cancer	0.00057	0.000613	CcSEcCtD
Hyoscyamine—Sweating—Methotrexate—lung cancer	0.000563	0.000605	CcSEcCtD
Hyoscyamine—Palpitations—Docetaxel—lung cancer	0.000563	0.000605	CcSEcCtD
Hyoscyamine—Feeling abnormal—Cisplatin—lung cancer	0.000562	0.000604	CcSEcCtD
Hyoscyamine—Loss of consciousness—Docetaxel—lung cancer	0.00056	0.000601	CcSEcCtD
Hyoscyamine—Dyspnoea—Etoposide—lung cancer	0.000557	0.000599	CcSEcCtD
Hyoscyamine—Somnolence—Etoposide—lung cancer	0.000556	0.000597	CcSEcCtD
Hyoscyamine—Angina pectoris—Doxorubicin—lung cancer	0.000555	0.000597	CcSEcCtD
Hyoscyamine—Insomnia—Paclitaxel—lung cancer	0.000554	0.000596	CcSEcCtD
Hyoscyamine—Hypersensitivity—Irinotecan—lung cancer	0.000554	0.000595	CcSEcCtD
Hyoscyamine—Convulsion—Docetaxel—lung cancer	0.000552	0.000593	CcSEcCtD
Hyoscyamine—Dyspnoea—Paclitaxel—lung cancer	0.000547	0.000587	CcSEcCtD
Hyoscyamine—Somnolence—Paclitaxel—lung cancer	0.000545	0.000586	CcSEcCtD
Hyoscyamine—Chest pain—Docetaxel—lung cancer	0.000542	0.000582	CcSEcCtD
Hyoscyamine—Nausea—Vinorelbine—lung cancer	0.000541	0.000582	CcSEcCtD
Hyoscyamine—Dyspepsia—Paclitaxel—lung cancer	0.00054	0.00058	CcSEcCtD
Hyoscyamine—Body temperature increased—Cisplatin—lung cancer	0.000539	0.00058	CcSEcCtD
Hyoscyamine—Asthenia—Irinotecan—lung cancer	0.000539	0.00058	CcSEcCtD
Hyoscyamine—Fatigue—Etoposide—lung cancer	0.000539	0.000579	CcSEcCtD
Hyoscyamine—Constipation—Etoposide—lung cancer	0.000535	0.000575	CcSEcCtD
Hyoscyamine—Pain—Etoposide—lung cancer	0.000535	0.000575	CcSEcCtD
Hyoscyamine—Dysuria—Doxorubicin—lung cancer	0.000533	0.000573	CcSEcCtD
Hyoscyamine—Dry mouth—Docetaxel—lung cancer	0.00053	0.00057	CcSEcCtD
Hyoscyamine—Fatigue—Paclitaxel—lung cancer	0.000529	0.000568	CcSEcCtD
Hyoscyamine—Asthenia—Gemcitabine—lung cancer	0.000525	0.000565	CcSEcCtD
Hyoscyamine—Constipation—Paclitaxel—lung cancer	0.000524	0.000563	CcSEcCtD
Hyoscyamine—Pain—Paclitaxel—lung cancer	0.000524	0.000563	CcSEcCtD
Hyoscyamine—Confusional state—Docetaxel—lung cancer	0.000524	0.000563	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Docetaxel—lung cancer	0.00052	0.000558	CcSEcCtD
Hyoscyamine—Oedema—Docetaxel—lung cancer	0.00052	0.000558	CcSEcCtD
Hyoscyamine—Pruritus—Gemcitabine—lung cancer	0.000518	0.000557	CcSEcCtD
Hyoscyamine—Feeling abnormal—Etoposide—lung cancer	0.000515	0.000554	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Doxorubicin—lung cancer	0.000514	0.000553	CcSEcCtD
Hyoscyamine—Diarrhoea—Irinotecan—lung cancer	0.000514	0.000553	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Etoposide—lung cancer	0.000511	0.000549	CcSEcCtD
Hyoscyamine—Shock—Docetaxel—lung cancer	0.000511	0.000549	CcSEcCtD
Hyoscyamine—Drowsiness—Doxorubicin—lung cancer	0.000508	0.000546	CcSEcCtD
Hyoscyamine—Tachycardia—Docetaxel—lung cancer	0.000507	0.000545	CcSEcCtD
Hyoscyamine—Feeling abnormal—Paclitaxel—lung cancer	0.000505	0.000543	CcSEcCtD
Hyoscyamine—Hypersensitivity—Cisplatin—lung cancer	0.000503	0.00054	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000501	0.000539	CcSEcCtD
Hyoscyamine—Diarrhoea—Gemcitabine—lung cancer	0.000501	0.000538	CcSEcCtD
Hyoscyamine—Dizziness—Irinotecan—lung cancer	0.000497	0.000534	CcSEcCtD
Hyoscyamine—Urticaria—Etoposide—lung cancer	0.000497	0.000534	CcSEcCtD
Hyoscyamine—Abdominal pain—Etoposide—lung cancer	0.000494	0.000531	CcSEcCtD
Hyoscyamine—Body temperature increased—Etoposide—lung cancer	0.000494	0.000531	CcSEcCtD
Hyoscyamine—Conjunctivitis—Doxorubicin—lung cancer	0.000494	0.000531	CcSEcCtD
Hyoscyamine—Asthenia—Cisplatin—lung cancer	0.00049	0.000526	CcSEcCtD
Hyoscyamine—Sweating—Doxorubicin—lung cancer	0.000487	0.000524	CcSEcCtD
Hyoscyamine—Urticaria—Paclitaxel—lung cancer	0.000487	0.000523	CcSEcCtD
Hyoscyamine—Hypotension—Docetaxel—lung cancer	0.000486	0.000522	CcSEcCtD
Hyoscyamine—Body temperature increased—Paclitaxel—lung cancer	0.000485	0.000521	CcSEcCtD
Hyoscyamine—Abdominal pain—Paclitaxel—lung cancer	0.000485	0.000521	CcSEcCtD
Hyoscyamine—Vomiting—Irinotecan—lung cancer	0.000478	0.000514	CcSEcCtD
Hyoscyamine—Rash—Irinotecan—lung cancer	0.000474	0.000509	CcSEcCtD
Hyoscyamine—Dermatitis—Irinotecan—lung cancer	0.000473	0.000509	CcSEcCtD
Hyoscyamine—Headache—Irinotecan—lung cancer	0.000471	0.000506	CcSEcCtD
Hyoscyamine—Insomnia—Docetaxel—lung cancer	0.00047	0.000505	CcSEcCtD
Hyoscyamine—Diarrhoea—Cisplatin—lung cancer	0.000467	0.000502	CcSEcCtD
Hyoscyamine—Vomiting—Gemcitabine—lung cancer	0.000466	0.0005	CcSEcCtD
Hyoscyamine—Bradycardia—Doxorubicin—lung cancer	0.000465	0.000499	CcSEcCtD
Hyoscyamine—Dyspnoea—Docetaxel—lung cancer	0.000463	0.000498	CcSEcCtD
Hyoscyamine—Somnolence—Docetaxel—lung cancer	0.000462	0.000496	CcSEcCtD
Hyoscyamine—Mental disorder—Methotrexate—lung cancer	0.000462	0.000496	CcSEcCtD
Hyoscyamine—Rash—Gemcitabine—lung cancer	0.000462	0.000496	CcSEcCtD
Hyoscyamine—Dermatitis—Gemcitabine—lung cancer	0.000461	0.000496	CcSEcCtD
Hyoscyamine—Hypersensitivity—Etoposide—lung cancer	0.000461	0.000495	CcSEcCtD
Hyoscyamine—Erythema—Methotrexate—lung cancer	0.000459	0.000493	CcSEcCtD
Hyoscyamine—Headache—Gemcitabine—lung cancer	0.000459	0.000493	CcSEcCtD
Hyoscyamine—Dyspepsia—Docetaxel—lung cancer	0.000457	0.000492	CcSEcCtD
Hyoscyamine—Hypersensitivity—Paclitaxel—lung cancer	0.000452	0.000485	CcSEcCtD
Hyoscyamine—Dysgeusia—Methotrexate—lung cancer	0.000449	0.000483	CcSEcCtD
Hyoscyamine—Asthenia—Etoposide—lung cancer	0.000449	0.000482	CcSEcCtD
Hyoscyamine—Fatigue—Docetaxel—lung cancer	0.000448	0.000481	CcSEcCtD
Hyoscyamine—Nausea—Irinotecan—lung cancer	0.000446	0.00048	CcSEcCtD
Hyoscyamine—Pain—Docetaxel—lung cancer	0.000444	0.000478	CcSEcCtD
Hyoscyamine—Constipation—Docetaxel—lung cancer	0.000444	0.000478	CcSEcCtD
Hyoscyamine—Pruritus—Etoposide—lung cancer	0.000442	0.000475	CcSEcCtD
Hyoscyamine—Asthenia—Paclitaxel—lung cancer	0.00044	0.000473	CcSEcCtD
Hyoscyamine—Nausea—Gemcitabine—lung cancer	0.000435	0.000467	CcSEcCtD
Hyoscyamine—Vomiting—Cisplatin—lung cancer	0.000434	0.000466	CcSEcCtD
Hyoscyamine—Pruritus—Paclitaxel—lung cancer	0.000434	0.000466	CcSEcCtD
Hyoscyamine—Vision blurred—Methotrexate—lung cancer	0.000432	0.000465	CcSEcCtD
Hyoscyamine—Rash—Cisplatin—lung cancer	0.00043	0.000462	CcSEcCtD
Hyoscyamine—Dermatitis—Cisplatin—lung cancer	0.00043	0.000462	CcSEcCtD
Hyoscyamine—Feeling abnormal—Docetaxel—lung cancer	0.000428	0.00046	CcSEcCtD
Hyoscyamine—Diarrhoea—Etoposide—lung cancer	0.000428	0.00046	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Docetaxel—lung cancer	0.000425	0.000457	CcSEcCtD
Hyoscyamine—Flushing—Doxorubicin—lung cancer	0.000424	0.000455	CcSEcCtD
Hyoscyamine—Diarrhoea—Paclitaxel—lung cancer	0.000419	0.000451	CcSEcCtD
Hyoscyamine—Dizziness—Etoposide—lung cancer	0.000413	0.000444	CcSEcCtD
Hyoscyamine—Vertigo—Methotrexate—lung cancer	0.000412	0.000443	CcSEcCtD
Hyoscyamine—Abdominal pain—Docetaxel—lung cancer	0.000411	0.000441	CcSEcCtD
Hyoscyamine—Body temperature increased—Docetaxel—lung cancer	0.000411	0.000441	CcSEcCtD
Hyoscyamine—Arrhythmia—Doxorubicin—lung cancer	0.000408	0.000438	CcSEcCtD
Hyoscyamine—Dizziness—Paclitaxel—lung cancer	0.000405	0.000436	CcSEcCtD
Hyoscyamine—Nausea—Cisplatin—lung cancer	0.000405	0.000436	CcSEcCtD
Hyoscyamine—Mental disorder—Doxorubicin—lung cancer	0.0004	0.00043	CcSEcCtD
Hyoscyamine—Convulsion—Methotrexate—lung cancer	0.000398	0.000427	CcSEcCtD
Hyoscyamine—Vomiting—Etoposide—lung cancer	0.000398	0.000427	CcSEcCtD
Hyoscyamine—Erythema—Doxorubicin—lung cancer	0.000397	0.000427	CcSEcCtD
Hyoscyamine—Rash—Etoposide—lung cancer	0.000394	0.000424	CcSEcCtD
Hyoscyamine—Dermatitis—Etoposide—lung cancer	0.000394	0.000423	CcSEcCtD
Hyoscyamine—Headache—Etoposide—lung cancer	0.000392	0.000421	CcSEcCtD
Hyoscyamine—Chest pain—Methotrexate—lung cancer	0.000391	0.00042	CcSEcCtD
Hyoscyamine—Tension—Doxorubicin—lung cancer	0.00039	0.000419	CcSEcCtD
Hyoscyamine—Vomiting—Paclitaxel—lung cancer	0.00039	0.000419	CcSEcCtD
Hyoscyamine—Dysgeusia—Doxorubicin—lung cancer	0.000389	0.000418	CcSEcCtD
Hyoscyamine—Rash—Paclitaxel—lung cancer	0.000387	0.000415	CcSEcCtD
Hyoscyamine—Dermatitis—Paclitaxel—lung cancer	0.000386	0.000415	CcSEcCtD
Hyoscyamine—Nervousness—Doxorubicin—lung cancer	0.000386	0.000415	CcSEcCtD
Hyoscyamine—Headache—Paclitaxel—lung cancer	0.000384	0.000413	CcSEcCtD
Hyoscyamine—Hypersensitivity—Docetaxel—lung cancer	0.000383	0.000411	CcSEcCtD
Hyoscyamine—Confusional state—Methotrexate—lung cancer	0.000378	0.000406	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Methotrexate—lung cancer	0.000374	0.000402	CcSEcCtD
Hyoscyamine—Vision blurred—Doxorubicin—lung cancer	0.000374	0.000402	CcSEcCtD
Hyoscyamine—Asthenia—Docetaxel—lung cancer	0.000373	0.000401	CcSEcCtD
Hyoscyamine—Nausea—Etoposide—lung cancer	0.000371	0.000399	CcSEcCtD
Hyoscyamine—Pruritus—Docetaxel—lung cancer	0.000368	0.000395	CcSEcCtD
Hyoscyamine—Agitation—Doxorubicin—lung cancer	0.000365	0.000392	CcSEcCtD
Hyoscyamine—Nausea—Paclitaxel—lung cancer	0.000364	0.000391	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Methotrexate—lung cancer	0.000362	0.000389	CcSEcCtD
Hyoscyamine—Vertigo—Doxorubicin—lung cancer	0.000357	0.000384	CcSEcCtD
Hyoscyamine—Syncope—Doxorubicin—lung cancer	0.000356	0.000383	CcSEcCtD
Hyoscyamine—Diarrhoea—Docetaxel—lung cancer	0.000356	0.000382	CcSEcCtD
Hyoscyamine—Palpitations—Doxorubicin—lung cancer	0.000351	0.000377	CcSEcCtD
Hyoscyamine—Hypotension—Methotrexate—lung cancer	0.00035	0.000376	CcSEcCtD
Hyoscyamine—Loss of consciousness—Doxorubicin—lung cancer	0.000349	0.000375	CcSEcCtD
Hyoscyamine—Convulsion—Doxorubicin—lung cancer	0.000344	0.00037	CcSEcCtD
Hyoscyamine—Dizziness—Docetaxel—lung cancer	0.000344	0.000369	CcSEcCtD
Hyoscyamine—Insomnia—Methotrexate—lung cancer	0.000339	0.000364	CcSEcCtD
Hyoscyamine—Chest pain—Doxorubicin—lung cancer	0.000338	0.000364	CcSEcCtD
Hyoscyamine—Anxiety—Doxorubicin—lung cancer	0.000337	0.000362	CcSEcCtD
Hyoscyamine—Dyspnoea—Methotrexate—lung cancer	0.000334	0.000359	CcSEcCtD
Hyoscyamine—Somnolence—Methotrexate—lung cancer	0.000333	0.000358	CcSEcCtD
Hyoscyamine—Dry mouth—Doxorubicin—lung cancer	0.000331	0.000356	CcSEcCtD
Hyoscyamine—Vomiting—Docetaxel—lung cancer	0.00033	0.000355	CcSEcCtD
Hyoscyamine—Dyspepsia—Methotrexate—lung cancer	0.00033	0.000354	CcSEcCtD
Hyoscyamine—Rash—Docetaxel—lung cancer	0.000328	0.000352	CcSEcCtD
Hyoscyamine—Dermatitis—Docetaxel—lung cancer	0.000327	0.000352	CcSEcCtD
Hyoscyamine—Confusional state—Doxorubicin—lung cancer	0.000327	0.000351	CcSEcCtD
Hyoscyamine—Headache—Docetaxel—lung cancer	0.000326	0.00035	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Doxorubicin—lung cancer	0.000324	0.000348	CcSEcCtD
Hyoscyamine—Oedema—Doxorubicin—lung cancer	0.000324	0.000348	CcSEcCtD
Hyoscyamine—Fatigue—Methotrexate—lung cancer	0.000323	0.000347	CcSEcCtD
Hyoscyamine—Pain—Methotrexate—lung cancer	0.00032	0.000344	CcSEcCtD
Hyoscyamine—Shock—Doxorubicin—lung cancer	0.000319	0.000343	CcSEcCtD
Hyoscyamine—Tachycardia—Doxorubicin—lung cancer	0.000316	0.00034	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Doxorubicin—lung cancer	0.000313	0.000337	CcSEcCtD
Hyoscyamine—Nausea—Docetaxel—lung cancer	0.000309	0.000332	CcSEcCtD
Hyoscyamine—Feeling abnormal—Methotrexate—lung cancer	0.000309	0.000332	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Methotrexate—lung cancer	0.000306	0.000329	CcSEcCtD
Hyoscyamine—Hypotension—Doxorubicin—lung cancer	0.000303	0.000326	CcSEcCtD
Hyoscyamine—Urticaria—Methotrexate—lung cancer	0.000298	0.00032	CcSEcCtD
Hyoscyamine—Abdominal pain—Methotrexate—lung cancer	0.000296	0.000318	CcSEcCtD
Hyoscyamine—Body temperature increased—Methotrexate—lung cancer	0.000296	0.000318	CcSEcCtD
Hyoscyamine—Insomnia—Doxorubicin—lung cancer	0.000293	0.000315	CcSEcCtD
Hyoscyamine—Dyspnoea—Doxorubicin—lung cancer	0.000289	0.000311	CcSEcCtD
Hyoscyamine—Somnolence—Doxorubicin—lung cancer	0.000288	0.00031	CcSEcCtD
Hyoscyamine—Dyspepsia—Doxorubicin—lung cancer	0.000285	0.000307	CcSEcCtD
Hyoscyamine—Fatigue—Doxorubicin—lung cancer	0.00028	0.0003	CcSEcCtD
Hyoscyamine—Pain—Doxorubicin—lung cancer	0.000277	0.000298	CcSEcCtD
Hyoscyamine—Constipation—Doxorubicin—lung cancer	0.000277	0.000298	CcSEcCtD
Hyoscyamine—Hypersensitivity—Methotrexate—lung cancer	0.000276	0.000297	CcSEcCtD
Hyoscyamine—Asthenia—Methotrexate—lung cancer	0.000269	0.000289	CcSEcCtD
Hyoscyamine—Feeling abnormal—Doxorubicin—lung cancer	0.000267	0.000287	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Doxorubicin—lung cancer	0.000265	0.000285	CcSEcCtD
Hyoscyamine—Pruritus—Methotrexate—lung cancer	0.000265	0.000285	CcSEcCtD
Hyoscyamine—Urticaria—Doxorubicin—lung cancer	0.000258	0.000277	CcSEcCtD
Hyoscyamine—Body temperature increased—Doxorubicin—lung cancer	0.000256	0.000275	CcSEcCtD
Hyoscyamine—Abdominal pain—Doxorubicin—lung cancer	0.000256	0.000275	CcSEcCtD
Hyoscyamine—Diarrhoea—Methotrexate—lung cancer	0.000256	0.000275	CcSEcCtD
Hyoscyamine—Dizziness—Methotrexate—lung cancer	0.000248	0.000266	CcSEcCtD
Hyoscyamine—Hypersensitivity—Doxorubicin—lung cancer	0.000239	0.000257	CcSEcCtD
Hyoscyamine—Vomiting—Methotrexate—lung cancer	0.000238	0.000256	CcSEcCtD
Hyoscyamine—Rash—Methotrexate—lung cancer	0.000236	0.000254	CcSEcCtD
Hyoscyamine—Dermatitis—Methotrexate—lung cancer	0.000236	0.000254	CcSEcCtD
Hyoscyamine—Headache—Methotrexate—lung cancer	0.000235	0.000252	CcSEcCtD
Hyoscyamine—Asthenia—Doxorubicin—lung cancer	0.000233	0.00025	CcSEcCtD
Hyoscyamine—Pruritus—Doxorubicin—lung cancer	0.000229	0.000247	CcSEcCtD
Hyoscyamine—Nausea—Methotrexate—lung cancer	0.000222	0.000239	CcSEcCtD
Hyoscyamine—Diarrhoea—Doxorubicin—lung cancer	0.000222	0.000238	CcSEcCtD
Hyoscyamine—Dizziness—Doxorubicin—lung cancer	0.000214	0.00023	CcSEcCtD
Hyoscyamine—Vomiting—Doxorubicin—lung cancer	0.000206	0.000222	CcSEcCtD
Hyoscyamine—Rash—Doxorubicin—lung cancer	0.000204	0.00022	CcSEcCtD
Hyoscyamine—Dermatitis—Doxorubicin—lung cancer	0.000204	0.00022	CcSEcCtD
Hyoscyamine—Headache—Doxorubicin—lung cancer	0.000203	0.000218	CcSEcCtD
Hyoscyamine—Nausea—Doxorubicin—lung cancer	0.000193	0.000207	CcSEcCtD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CG—lung cancer	2.6e-05	0.000401	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—APC—lung cancer	2.6e-05	0.000401	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—KIT—lung cancer	2.6e-05	0.000401	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—NRAS—lung cancer	2.6e-05	0.000401	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—MAP2K1—lung cancer	2.59e-05	0.0004	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CD—lung cancer	2.58e-05	0.000397	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—EGF—lung cancer	2.57e-05	0.000396	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AVP—lung cancer	2.51e-05	0.000387	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PIK3CB—lung cancer	2.51e-05	0.000386	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AVP—lung cancer	2.5e-05	0.000386	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PIK3CB—lung cancer	2.5e-05	0.000385	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—MAPK3—lung cancer	2.49e-05	0.000384	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AVP—lung cancer	2.48e-05	0.000382	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—POMC—lung cancer	2.48e-05	0.000382	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PIK3CB—lung cancer	2.47e-05	0.000381	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—BRAF—lung cancer	2.45e-05	0.000377	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IGF1R—lung cancer	2.42e-05	0.000373	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL6R—lung cancer	2.42e-05	0.000372	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CREBBP—lung cancer	2.41e-05	0.000372	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IGF1R—lung cancer	2.41e-05	0.000372	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CXCL8—lung cancer	2.41e-05	0.000371	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CXCL8—lung cancer	2.4e-05	0.00037	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IGF1R—lung cancer	2.39e-05	0.000368	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CXCL8—lung cancer	2.38e-05	0.000366	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HES1—lung cancer	2.38e-05	0.000366	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—EGFR—lung cancer	2.37e-05	0.000365	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HES1—lung cancer	2.37e-05	0.000365	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HES1—lung cancer	2.35e-05	0.000362	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—RAF1—lung cancer	2.33e-05	0.000359	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—RAF1—lung cancer	2.32e-05	0.000358	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MAP2K1—lung cancer	2.3e-05	0.000355	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—IL2—lung cancer	2.3e-05	0.000355	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—RAF1—lung cancer	2.3e-05	0.000355	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—IL2—lung cancer	2.29e-05	0.000354	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—APOA1—lung cancer	2.29e-05	0.000353	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CD—lung cancer	2.29e-05	0.000353	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CB—lung cancer	2.28e-05	0.000351	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—IL2—lung cancer	2.27e-05	0.00035	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CB—lung cancer	2.27e-05	0.00035	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—PIK3CA—lung cancer	2.27e-05	0.000349	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CB—lung cancer	2.25e-05	0.000346	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—KRAS—lung cancer	2.24e-05	0.000345	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CXCL8—lung cancer	2.19e-05	0.000337	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CXCL8—lung cancer	2.18e-05	0.000336	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ERBB3—lung cancer	2.17e-05	0.000335	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ERBB3—lung cancer	2.17e-05	0.000334	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CXCL8—lung cancer	2.16e-05	0.000333	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ERBB3—lung cancer	2.14e-05	0.000331	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CG—lung cancer	2.09e-05	0.000322	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL2—lung cancer	2.09e-05	0.000322	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL2—lung cancer	2.08e-05	0.000321	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TERT—lung cancer	2.08e-05	0.000321	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TERT—lung cancer	2.08e-05	0.00032	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL2—lung cancer	2.06e-05	0.000318	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—PIK3CA—lung cancer	2.06e-05	0.000317	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TERT—lung cancer	2.06e-05	0.000317	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MDM2—lung cancer	2.05e-05	0.000316	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—RAF1—lung cancer	2.04e-05	0.000315	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FGFR1—lung cancer	2.02e-05	0.000312	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ERBB2—lung cancer	2.02e-05	0.000311	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FGFR1—lung cancer	2.02e-05	0.000311	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FGFR1—lung cancer	2e-05	0.000308	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MTOR—lung cancer	1.99e-05	0.000307	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CB—lung cancer	1.99e-05	0.000307	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HIF1A—lung cancer	1.99e-05	0.000307	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—POMC—lung cancer	1.99e-05	0.000307	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HIF1A—lung cancer	1.98e-05	0.000306	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HIF1A—lung cancer	1.97e-05	0.000303	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CREBBP—lung cancer	1.94e-05	0.000299	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—APOA1—lung cancer	1.92e-05	0.000296	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CXCL8—lung cancer	1.92e-05	0.000295	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—APOA1—lung cancer	1.92e-05	0.000295	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KDR—lung cancer	1.9e-05	0.000294	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—HRAS—lung cancer	1.9e-05	0.000293	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KDR—lung cancer	1.9e-05	0.000293	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—APOA1—lung cancer	1.9e-05	0.000292	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KDR—lung cancer	1.88e-05	0.00029	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—AKT1—lung cancer	1.85e-05	0.000285	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CD—lung cancer	1.84e-05	0.000283	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CASP3—lung cancer	1.83e-05	0.000283	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL2—lung cancer	1.83e-05	0.000282	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—IL6—lung cancer	1.82e-05	0.000281	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ALB—lung cancer	1.81e-05	0.00028	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCND1—lung cancer	1.78e-05	0.000275	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—JUN—lung cancer	1.78e-05	0.000275	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—APC—lung cancer	1.75e-05	0.00027	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KIT—lung cancer	1.75e-05	0.00027	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CG—lung cancer	1.75e-05	0.00027	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—NRAS—lung cancer	1.75e-05	0.00027	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CG—lung cancer	1.75e-05	0.00027	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KIT—lung cancer	1.75e-05	0.00027	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—APC—lung cancer	1.75e-05	0.00027	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—NRAS—lung cancer	1.75e-05	0.00027	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EGF—lung cancer	1.73e-05	0.000267	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MMP9—lung cancer	1.73e-05	0.000267	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CG—lung cancer	1.73e-05	0.000267	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—APC—lung cancer	1.73e-05	0.000267	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KIT—lung cancer	1.73e-05	0.000267	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—NRAS—lung cancer	1.73e-05	0.000267	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EGF—lung cancer	1.73e-05	0.000266	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CDKN1A—lung cancer	1.73e-05	0.000266	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PTEN—lung cancer	1.72e-05	0.000266	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EGF—lung cancer	1.71e-05	0.000264	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—AKT1—lung cancer	1.68e-05	0.000259	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—MAPK3—lung cancer	1.68e-05	0.000259	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—MAPK3—lung cancer	1.67e-05	0.000258	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—POMC—lung cancer	1.67e-05	0.000257	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—POMC—lung cancer	1.66e-05	0.000257	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—MAPK3—lung cancer	1.66e-05	0.000256	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—BRAF—lung cancer	1.65e-05	0.000254	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—POMC—lung cancer	1.65e-05	0.000254	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—BRAF—lung cancer	1.64e-05	0.000253	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—EP300—lung cancer	1.64e-05	0.000253	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL6R—lung cancer	1.63e-05	0.000251	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—BRAF—lung cancer	1.63e-05	0.000251	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CREBBP—lung cancer	1.63e-05	0.000251	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL6R—lung cancer	1.62e-05	0.00025	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CREBBP—lung cancer	1.62e-05	0.00025	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL6R—lung cancer	1.61e-05	0.000248	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CREBBP—lung cancer	1.61e-05	0.000248	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CB—lung cancer	1.6e-05	0.000247	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—EGFR—lung cancer	1.6e-05	0.000246	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SRC—lung cancer	1.6e-05	0.000246	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—EGFR—lung cancer	1.59e-05	0.000246	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PTGS2—lung cancer	1.59e-05	0.000245	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—EGFR—lung cancer	1.58e-05	0.000243	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—VEGFA—lung cancer	1.56e-05	0.00024	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MAP2K1—lung cancer	1.55e-05	0.000239	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MAP2K1—lung cancer	1.55e-05	0.000239	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CD—lung cancer	1.54e-05	0.000238	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—STAT3—lung cancer	1.54e-05	0.000237	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CD—lung cancer	1.54e-05	0.000237	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NRAS—lung cancer	1.54e-05	0.000237	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MAP2K1—lung cancer	1.53e-05	0.000236	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PIK3CA—lung cancer	1.53e-05	0.000235	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PIK3CA—lung cancer	1.52e-05	0.000235	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CD—lung cancer	1.52e-05	0.000235	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—KRAS—lung cancer	1.51e-05	0.000233	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	1.51e-05	0.000232	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—KRAS—lung cancer	1.5e-05	0.000232	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—KRAS—lung cancer	1.49e-05	0.00023	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MAPK3—lung cancer	1.47e-05	0.000227	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MYC—lung cancer	1.43e-05	0.000221	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—EGFR—lung cancer	1.4e-05	0.000216	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CA—lung cancer	1.39e-05	0.000214	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PTEN—lung cancer	1.38e-05	0.000213	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CA—lung cancer	1.38e-05	0.000213	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MDM2—lung cancer	1.38e-05	0.000213	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MDM2—lung cancer	1.38e-05	0.000212	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—RAF1—lung cancer	1.38e-05	0.000212	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—RAF1—lung cancer	1.37e-05	0.000212	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	1.37e-05	0.000211	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MDM2—lung cancer	1.36e-05	0.00021	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ERBB2—lung cancer	1.36e-05	0.00021	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—RAF1—lung cancer	1.36e-05	0.00021	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ERBB2—lung cancer	1.36e-05	0.000209	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ERBB2—lung cancer	1.34e-05	0.000207	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MTOR—lung cancer	1.34e-05	0.000207	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CB—lung cancer	1.34e-05	0.000207	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MTOR—lung cancer	1.34e-05	0.000207	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CB—lung cancer	1.34e-05	0.000207	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CB—lung cancer	1.33e-05	0.000205	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MTOR—lung cancer	1.33e-05	0.000205	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—KRAS—lung cancer	1.32e-05	0.000204	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—EP300—lung cancer	1.32e-05	0.000204	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCL8—lung cancer	1.29e-05	0.000199	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCL8—lung cancer	1.29e-05	0.000198	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—HRAS—lung cancer	1.28e-05	0.000198	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—HRAS—lung cancer	1.28e-05	0.000197	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCL8—lung cancer	1.28e-05	0.000197	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—HRAS—lung cancer	1.27e-05	0.000195	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—AKT1—lung cancer	1.25e-05	0.000192	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—AKT1—lung cancer	1.24e-05	0.000192	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CASP3—lung cancer	1.24e-05	0.000191	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL2—lung cancer	1.23e-05	0.00019	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CASP3—lung cancer	1.23e-05	0.00019	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—AKT1—lung cancer	1.23e-05	0.00019	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL2—lung cancer	1.23e-05	0.00019	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL6—lung cancer	1.23e-05	0.000189	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL6—lung cancer	1.22e-05	0.000189	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CASP3—lung cancer	1.22e-05	0.000188	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL2—lung cancer	1.22e-05	0.000188	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CA—lung cancer	1.22e-05	0.000187	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL6—lung cancer	1.21e-05	0.000187	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCND1—lung cancer	1.2e-05	0.000186	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—JUN—lung cancer	1.2e-05	0.000185	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCND1—lung cancer	1.2e-05	0.000185	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—JUN—lung cancer	1.2e-05	0.000185	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCND1—lung cancer	1.19e-05	0.000183	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—JUN—lung cancer	1.19e-05	0.000183	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TP53—lung cancer	1.18e-05	0.000181	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MMP9—lung cancer	1.17e-05	0.00018	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MMP9—lung cancer	1.16e-05	0.00018	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CDKN1A—lung cancer	1.16e-05	0.000179	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PTEN—lung cancer	1.16e-05	0.000179	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CDKN1A—lung cancer	1.16e-05	0.000179	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PTEN—lung cancer	1.16e-05	0.000178	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MMP9—lung cancer	1.15e-05	0.000178	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CDKN1A—lung cancer	1.15e-05	0.000177	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PTEN—lung cancer	1.15e-05	0.000177	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AKT1—lung cancer	1.13e-05	0.000175	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AKT1—lung cancer	1.13e-05	0.000174	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—HRAS—lung cancer	1.12e-05	0.000173	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AKT1—lung cancer	1.12e-05	0.000172	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EP300—lung cancer	1.11e-05	0.000171	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EP300—lung cancer	1.1e-05	0.00017	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EP300—lung cancer	1.09e-05	0.000169	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SRC—lung cancer	1.08e-05	0.000166	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL6—lung cancer	1.08e-05	0.000166	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SRC—lung cancer	1.07e-05	0.000166	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SRC—lung cancer	1.06e-05	0.000164	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—VEGFA—lung cancer	1.05e-05	0.000162	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—VEGFA—lung cancer	1.05e-05	0.000161	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—STAT3—lung cancer	1.04e-05	0.00016	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NRAS—lung cancer	1.04e-05	0.00016	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—VEGFA—lung cancer	1.04e-05	0.00016	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—STAT3—lung cancer	1.04e-05	0.00016	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NRAS—lung cancer	1.03e-05	0.000159	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—STAT3—lung cancer	1.03e-05	0.000158	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NRAS—lung cancer	1.02e-05	0.000158	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AKT1—lung cancer	9.93e-06	0.000153	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MAPK3—lung cancer	9.92e-06	0.000153	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MAPK3—lung cancer	9.89e-06	0.000153	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MAPK3—lung cancer	9.8e-06	0.000151	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CA—lung cancer	9.77e-06	0.000151	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MYC—lung cancer	9.65e-06	0.000149	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MYC—lung cancer	9.62e-06	0.000148	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MYC—lung cancer	9.53e-06	0.000147	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EGFR—lung cancer	9.44e-06	0.000146	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EGFR—lung cancer	9.41e-06	0.000145	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EGFR—lung cancer	9.32e-06	0.000144	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KRAS—lung cancer	8.92e-06	0.000137	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KRAS—lung cancer	8.89e-06	0.000137	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KRAS—lung cancer	8.8e-06	0.000136	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CA—lung cancer	8.19e-06	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CA—lung cancer	8.17e-06	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CA—lung cancer	8.09e-06	0.000125	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—AKT1—lung cancer	7.98e-06	0.000123	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TP53—lung cancer	7.93e-06	0.000122	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TP53—lung cancer	7.9e-06	0.000122	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TP53—lung cancer	7.82e-06	0.000121	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HRAS—lung cancer	7.58e-06	0.000117	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HRAS—lung cancer	7.56e-06	0.000116	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HRAS—lung cancer	7.48e-06	0.000115	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL6—lung cancer	7.26e-06	0.000112	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL6—lung cancer	7.23e-06	0.000111	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL6—lung cancer	7.16e-06	0.00011	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKT1—lung cancer	6.69e-06	0.000103	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKT1—lung cancer	6.67e-06	0.000103	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKT1—lung cancer	6.61e-06	0.000102	CbGpPWpGaD
